BNP Paribas Financial Markets’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.5M Buy
1,298,459
+187,750
+17% +$3.25M 0.01% 746
2025
Q1
$24.3M Buy
1,110,709
+259,886
+31% +$5.68M 0.01% 693
2024
Q4
$27.1M Buy
850,823
+691,123
+433% +$22.1M 0.02% 641
2024
Q3
$4.61M Buy
159,700
+55,282
+53% +$1.59M ﹤0.01% 1042
2024
Q2
$4.01M Buy
104,418
+52,792
+102% +$2.03M ﹤0.01% 1054
2024
Q1
$3.03M Sell
51,626
-115,862
-69% -$6.81M ﹤0.01% 1305
2023
Q4
$10M Sell
167,488
-68,867
-29% -$4.12M 0.01% 694
2023
Q3
$8.99M Buy
236,355
+177,694
+303% +$6.76M 0.01% 650
2023
Q2
$5.34M Sell
58,661
-57,969
-50% -$5.28M 0.01% 857
2023
Q1
$7.69M Buy
116,630
+80,434
+222% +$5.31M 0.01% 747
2022
Q4
$1.87M Sell
36,196
-79,166
-69% -$4.09M ﹤0.01% 1282
2022
Q3
$7.88M Buy
115,362
+95,294
+475% +$6.51M 0.01% 784
2022
Q2
$907K Buy
20,068
+13,717
+216% +$620K ﹤0.01% 1704
2022
Q1
$323K Sell
6,351
-8,586
-57% -$436K ﹤0.01% 2410
2021
Q4
$706K Buy
14,937
+3,497
+31% +$165K ﹤0.01% 2224
2021
Q3
$377K Buy
11,440
+9,137
+397% +$301K ﹤0.01% 2281
2021
Q2
$146K Sell
2,303
-5,199
-69% -$329K ﹤0.01% 2352
2021
Q1
$322K Sell
7,502
-581
-7% -$24.9K ﹤0.01% 2273
2020
Q4
$462K Sell
8,083
-6,070
-43% -$347K ﹤0.01% 1889
2020
Q3
$427K Buy
14,153
+6,859
+94% +$207K ﹤0.01% 1737
2020
Q2
$238K Sell
7,294
-22,699
-76% -$741K ﹤0.01% 1825
2020
Q1
$804K Sell
29,993
-21,740
-42% -$582K ﹤0.01% 1561
2019
Q4
$1.58M Buy
51,733
+44,401
+606% +$1.36M ﹤0.01% 1267
2019
Q3
$177K Buy
7,332
+3,294
+82% +$79.4K ﹤0.01% 2210
2019
Q2
$102K Sell
4,038
-3,481
-46% -$88.2K ﹤0.01% 2416
2019
Q1
$147K Buy
7,519
+7,516
+250,533% +$147K ﹤0.01% 2311
2018
Q4
$40 Sell
3
-1,179
-100% -$15.7K ﹤0.01% 3582
2018
Q3
$21K Hold
1,182
﹤0.01% 2733
2018
Q2
$26K Sell
1,182
-773
-40% -$17K ﹤0.01% 2744
2018
Q1
$43.2K Sell
1,955
-295
-13% -$6.52K ﹤0.01% 3054
2017
Q4
$48.8K Buy
+2,250
New +$48.8K ﹤0.01% 3006